Patient self-management of anticoagulation therapy does not appear to be cost-eff-
ective, new UK research has concluded.
The study of 617 patients found costs were significantly higher in patients who self-managed than in those in
usual, clinic-based care.
But self-management had no significant benefits in quality-adjusted life years.
Study leader Sue Jowett, research fellow at the department of general practice and primary care, University of Birmingham, said: 'Patient self-management was more expensive than standard care.
'Treatment with the NHS costs around £420 per patient per year, compared with approximately £120 for routinely managed patients.
'It seems unlikely that this technology represents good value for money within the UK health care system.'
But her study, published in the latest issue of the British Journal of Haematology, cautions that self-management may still prove worthwhile for cutting referrals and freeing up specialist time.